Opexa Therapeutics Inc (OPXA) - Medical Equipment - Deals and Alliances Profile
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Summary
Opexa Therapeutics Inc (Opexa), formerly PharmaFrontiers Corp. is a biopharmaceutical company that focuses on the development of personalized immunotherapies for autoimmune disorders, rheumatoid arthritis, diabetes and heart failure. The companys portfolio of products comprise Tcelna, a T-cell immunotherapy used for the treatment of secondary progressive multiple sclerosis; OPX-212, for neuromyelitis optica. The company uses T-cell technology platform for the development of patient-specific T-cell therapies. It operates in the US and Canada. Opexa is headquartered in the Woodlands, Texas, the US.
Opexa Therapeutics Inc (OPXA) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Opexa Therapeutics Inc (Opexa), formerly PharmaFrontiers Corp. is a biopharmaceutical company that focuses on the development of personalized immunotherapies for autoimmune disorders, rheumatoid arthritis, diabetes and heart failure. The companys portfolio of products comprise Tcelna, a T-cell immunotherapy used for the treatment of secondary progressive multiple sclerosis; OPX-212, for neuromyelitis optica. The company uses T-cell technology platform for the development of patient-specific T-cell therapies. It operates in the US and Canada. Opexa is headquartered in the Woodlands, Texas, the US.
Opexa Therapeutics Inc (OPXA) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
TABLE OF CONTENTS
2
List of Tables 3
List of Figures 4
Opexa Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Opexa Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Opexa Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Opexa Therapeutics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Opexa Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Opexa Therapeutics Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Opexa Therapeutics Raises USD13.8 Million in Rights Offering of Units 10
Opexa Therapeutics Completes Public Offering Of Shares For US$8 Million 11
Opexa Therapeutics Completes Underwriters Exercise Of Partial Over-Allotment Option For Public Offering Of Shares For US$19 Million 12
Opexa Therapeutics Completes Private Placement Of Shares For US$0.5 Million 14
Opexa Therapeutics Completes Private Placement Of Units For US$3.2 Million 15
Opexa Therapeutics Private Placement Of Common Stock For US$0.5 Million 16
Opexa Therapeutics Files Prospectus For Public Offering Of Shares 17
Opexa Therapeutics Completes First Tranche Of Private Placement Of Shares For US$0.05 Million 17
Opexa Therapeutics Completes An Underwritten Public Offering For US$8.5 Million 19
Opexa Therapeutics Completes Private Placement Of Common Stock For US$1.1 Million 20
Opexa Therapeutics Inc - Key Competitors 22
Key Employees 23
Locations And Subsidiaries 24
Head Office 24
Recent Developments 25
Financial Announcements 25
Nov 14, 2016: Opexa Therapeutics Reports Third Quarter 2016 Financial Results and Provides Corporate Update 25
Aug 11, 2016: Opexa Therapeutics Reports Second Quarter 2016 Financial Results and Provides Corporate Update 26
May 12, 2016: Opexa Therapeutics Reports First Quarter 2016 Financial Results and Provides Corporate Update 28
Mar 15, 2016: Opexa Therapeutics Reports 2015 Year End Financial Results and Provides Corporate Update 30
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32
List Of Tables
Opexa Therapeutics Inc, Medical Equipment, Key Facts, 2015 1
Opexa Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 1
Opexa Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Opexa Therapeutics Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Opexa Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Opexa Therapeutics Inc, Deals By Market, 2011 to YTD 2017 8
Opexa Therapeutics Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Opexa Therapeutics Raises USD13.8 Million in Rights Offering of Units 10
Opexa Therapeutics Completes Public Offering Of Shares For US$8 Million 11
Opexa Therapeutics Completes Underwriters Exercise Of Partial Over-Allotment Option For Public Offering Of Shares For US$19 Million 12
Opexa Therapeutics Completes Private Placement Of Shares For US$0.5 Million 14
Opexa Therapeutics Completes Private Placement Of Units For US$3.2 Million 15
Opexa Therapeutics Private Placement Of Common Stock For US$0.5 Million 16
Opexa Therapeutics Files Prospectus For Public Offering Of Shares 17
Opexa Therapeutics Completes First Tranche Of Private Placement Of Shares For US$0.05 Million 17
Opexa Therapeutics Completes An Underwritten Public Offering For US$8.5 Million 19
Opexa Therapeutics Completes Private Placement Of Common Stock For US$1.1 Million 20
Opexa Therapeutics Inc, Key Competitors 22
Opexa Therapeutics Inc, Key Employees 23
List Of Figures
Opexa Therapeutics Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 1
Opexa Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 1
Opexa Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 1
Opexa Therapeutics Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 1
Opexa Therapeutics Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Opexa Therapeutics Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017 6
Opexa Therapeutics Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Opexa Therapeutics Inc, Medical Equipment, Deals by Market, 2011 to YTD 2017 8
RELATED REPORTS
Opexa Therapeutics Inc (OPXA) - Medical Equipment - Deals and Alliances Profile.
Opexa Therapeutics Inc (Opexa), formerly PharmaFrontiers Corp is a biotechnology company that develops personalized immunotherapies for the treatment of autoimmune disorders, rheumatoid arthritis, diabetes and heart failure. The companys products
View ReportAnika Therapeutics Inc (ANIK) - Product Pipeline Analysis, 2021 Update
Anika Therapeutics Inc (Anika) develops, manufactures, and markets therapeutic products for degenerative orthopedic diseases and traumatic conditions. It offers solutions for ortho-biologics, dermal, ophthalmic, surgical and veterinary applications. Its major
View ReportChinook Therapeutics Inc (KDNY) - Financial and Strategic SWOT Analysis Review
Chinook Therapeutics, Inc (Chinook)., formerly Aduro BioTech Inc is a clinical-stage immunotherapy company that discovers, develops and commercializes therapies for the treatment of cancer. The company develops product candidates using
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
